Publication Name	World Journal of Radiology
Manuscript ID	8707
Country	United States

Received	2014-01-03 16:10
Peer-Review Started	2014-01-03 21:03
To Make the First Decision	2014-01-23 17:10
Return for Revision	2014-02-09 21:10
Revised	2014-02-16 12:19
Second Decision	2014-03-14 18:22
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-14 18:35
Articles in Press	2014-05-23 12:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-20 11:23
Publish the Manuscript Online	2014-06-28 15:27

ISSN	1949-8470 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Topic Highlights
Article Title	Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers
Manuscript Source	Invited Manuscript
All Author List	Farzan Siddiqui and Min Yao
Funding Agency and Grant Number
Corresponding Author	Min Yao, MD, PhD, Department of Radiation Oncology, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, United States. min.yao@uhhospitals.org
Key Words	Fluorodeoxyglucose; Positron emission tomography; Squamous cell carcinoma; Head and neck cancer; Radiation therapy planning
Core Tip	Fluorodeoxyglucose positron emission tomography (FDG PET) computed tomography (CT) scans should be obtained for patients for squamous cell carcinoma of the head and neck whenever clinically indicated and feasible. Pre-treatment scans are helpful in detecting the sites of primary cancer, staging the tumor and ruling out the presence of distant metastases. For patients undergoing radiation therapy, PET/CT scans provide anatomic as well as functional information to aid in treatment planning. After completion of radiotherapy, PET scans should be obtained approximately 12 wk after treatment to assess treatment response and to determine if any salvage therapy is required for persistent, recurrent or metastatic disease.
Publish Date	2014-06-28 15:27
Citation	Siddiqui F, Yao M. Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers. World J Radiol 2014; 6(6): 238-251
URL	http://www.wjgnet.com/1949-8470/full/v6/i6/238.htm
DOI	http://dx.doi.org/10.4329/wjr.v6.i6.238

Full Article (PDF)	WJR-6-238.pdf
Full Article (Word)	WJR-6-238.doc
Manuscript File	8707-Review.docx
Answering Reviewers	8707-Answering reviewers.pdf
Copyright License Agreement	8707-Copyright assignment.pdf
Peer-review Report	8707-Peer review(s).pdf
Scientific Editor Work List	8707-Scientific editor work list.doc